News - Management

Filter

Current filters:

Management

Popular Filters

176 to 200 of 230 results

Chelsea Therapeutics and Savient to slash jobs

11-07-2012

Chelsea Therapeutics International (Nasdaq: CHTP) yesterday announced restructuring plans to "significantly…

BiotechnologyChelsea TherapeuticsFinancialKrystexxaManagementNortheraSavient Pharmaceuticals

News briefs from Merck KGaA and Sanofi

05-07-2012

German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

Roche to close Nutley, USA, site with 1,000 job losses

27-06-2012

Swiss drug major Roche (ROG: SIX) yesterday announced a consolidation and streamlining of research activities,…

FinancialManagementPharmaceuticalResearchRoche

Icahn tries again to nominate Forest Labs board members

20-06-2012

In a second proxy fight against US drugmaker Forest Laboratories (NYSE: FRX), billionaire investor Carl…

Forest LaboratoriesManagementPharmaceutical

Lundbeck restructures, with 600 job cuts anticipated

17-06-2012

Denmark-based CNS specialist Lundbeck (LUN: CO) last week announced plans to restructure its commercial…

FinancialLundbeckManagementNeurologicalPharmaceutical

Senior exec appointments at Pfizer

23-05-2012

Global pharma behemoth Pfizer (NYSE: PFE) has named Olivier Brandicourt as president and general manager…

ManagementPfizerPharmaceutical

Newron executes safinamide deal with Zambon; new Ph III data; management changes

15-05-2012

In what was a busy news day for Italian drug developer Newron Pharmaceuticals SpA (SIX: NWRN), the company…

FinancialLicensingManagementNeurologicalNewron PharmaPharmaceuticalResearchsafinamideZambon

Exec appointments at Novo Nordisk and Teva

09-05-2012

Danish insulin giant Novo Nordisk (NOV: N) says that former Pfizer executive Robert Clark will be joining…

GenericsManagementNovo NordiskPharmaceuticalTeva Pharmaceutical Industries

New business model to relaunch the BioPharma industry, from ADL

01-05-2012

Traditionally, clinical diagnoses and treatments have focused on diseases and cures. For every ailment,…

BiotechnologyManagementMarkets & MarketingPharmaceutical

AstraZeneca CEO to go early, as 1st-qtr sales and profits plunge; makes deal with TMC for cardiovasculars

26-04-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) stunned the markets this morning, announcing that its…

AstraZenecaCardio-vascularFinancialLicensingManagementPharmaceuticalThe Medicines Company

Merck KGaA to rationalize operations in Switzerland

24-04-2012

German drug major Merck KGaA (MRK: DE) has announced efficiency measures it plans to take related to…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalResearch

Senior exec changes actual or sought at Johnson & Johnson, AstraZeneca and Optimer

10-04-2012

US health care giant Johnson & Johnson (NYSE: JNJ) said on Monday that Sherilyn (Sheri) McCoy, vice chairman…

AstraZenecaJohnson & JohnsonManagementOptimer PharmaceuticalsPharmaceutical

Most admired pharma companies in Japan, by IAL

07-03-2012

Since 1999 International Alliances Limited (IAL), headed by P Reed Maurer, has conducted an annual survey…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Senior appointments as Sanofi and Onyx

05-03-2012

French drug major Sanofi (Euronext: SAN) has named former Bayer executive Jean-Luc Lowinski as senior…

ManagementOnyx PharmaceuticalsPharmaceuticalSanofi

EMA increases public information on conflicts of interest of experts and management

01-03-2012

The European Medicines Agency this week updated its list of European experts to display each expert's…

EuropeManagementPharmaceuticalRegulation

Merck KGaA sets out efficiency program, with cost and job cuts likely

26-02-2012

Adding to the list of pharma companies announcing significant structural changes and job cuts, on Friday…

FinancialManagementMerck KGaAPharmaceutical

Alex Gorsky named as CEO of Johnson & Johnson

22-02-2012

Troubled US health care giant Johnson & Johnson (NYSE: JNJ) last night announced that its board of directors…

Johnson & JohnsonManagementPharmaceutical

LEO Pharma sales reps file suit on overtime in USA

09-02-2012

Attorneys from Sanford Wittels & Heisler have filed a class action complaint in the US District Court…

LegalLEO PharmaManagementNorth AmericaPharmaceutical

Two hurdles to jump for SkyePharma, as it changes CEO

31-01-2012

On the same day that UK-based SkyePharma (LSE: SKP) announced that Axel Mueller has resigned as chief…

3MEuropeFinancialFlutiformManagementPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Novartis resolves US class action on wage and hour claims

25-01-2012

The US subsidiary of Swiss drug major Novartis (NOVN: VX) says it has reached an agreement to resolve…

LegalManagementNorth AmericaNovartisPharmaceutical

Alnylam looks to save $20 million via restructuring

22-01-2012

USA-based RNAi therapeutics specialist Alnylam Pharmaceuticals (Nasdaq: ALNY) said last week that it…

Alnylam PharmaceuticalsBiotechnologyFinancialManagement

Takeda cuts 2,800 jobs as it assimilates Nycomed

19-01-2012

Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) yesterday announced strategic measures…

FinancialManagementNycomedPharmaceuticalResearchTakeda Pharmaceuticals

Novartis cuts jobs, takes $1.22 billion charges

13-01-2012

In anticipation of the blockbuster antihypertensive Diovan’s (valsartan) patent expiration and an…

DiovanFinancialManagementNovartisPatentsPharmaceuticalRasilezTekturna

Knighthood for GlaxoSmithKline’s Andrew Witty; Teva succession plan

03-01-2012

Andrew Witty, chief executive of UK drug giant GlaxoSmithKline (LSE: GSK) has been awarded a Knighthood…

GenericsGlaxoSmithKlineManagementPharmaceuticalTeva Pharmaceutical Industries

176 to 200 of 230 results

Back to top